A newly identified brain network may be the real driver of Parkinson’s—and precisely targeting it just delivered a major boost in symptom relief.

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 ...

DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from FDAClinical entry ...

Lymphatic drainage massage gently moves lymph fluid to reduce swelling, support recovery, and improve circulation. Learn ...

Using AI-based compound-protein interaction modeling, Syntekabio has identified key disease targets for MetaVia's oral G-protein-coupled receptor 119 (GPR119) agonist, vanoglipel ...

CNN data analyst Harry Enten burst out laughing as he broke down the government’s historic dysfunction under Donald Trump. The data guru revealed on Tuesday that of all the days the government has ...

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2026 Earnings Call Transcript February 3, 2026 Operator: Good day, everyone. And ...

Some cancer therapies may be more effective when given earlier in the day, aligning treatment with the body's natural rhythms ...

Researchers compare dietary intake, diet quality, and dietary assessment methods among individuals with alcohol use disorder.

Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.

The Denver Broncos lost a heartbreaking AFC Championship game against the New England Patriots, 10-7, last month. What makes ...

The insulin resistance market is expected to grow steadily over the forecast period (2026--2036). According to DelveInsight's analysis, this growth is driven by the rising global prevalence of obesity ...